✦ LIBER ✦

Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine

✍ Scribed by Fumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, Norio Akuta, Hitomi Sezaki, Tasuku Hara, Yusuke Kawamura, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Rie Mineta, Hiromitsu Kumada…show all 15hide

Book ID: 120664366
Publisher: Springer Japan
Year: 2013
Tongue: English
Weight: 362 KB
Volume: 49
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-013-0864-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy of entecavir in adefo

Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance

✍ J. W. Park; H. S. Kim; D. D. Seo; J. S. Jang; W. G. Shin; K. H. Kim; M. K. Jang; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Low risk of adefovir resistance in lamiv

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up

✍ Hiromi Yatsuji; Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 238 KB

The Efficacy of Adefovir Plus Entecavir

The Efficacy of Adefovir Plus Entecavir Combination Therapy in Patients with Chronic Hepatitis B Refractory to Both Lamivudine and Adefovir

✍ Cho, Yuri; Lee, Dong Hyeon; Chung, Kwang Hyun; Jin, Eunhyo; Lee, Jeong-Hoon; Cho 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 264 KB

High risk of renal impairment during lon

High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B

✍ M. Viganò; P. Lampertico; M. Iavarone; G.E. Tontini; F. Facchetti; M. Colombo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB

HIGH RISK OF RENAL IMPAIRMENT DURING LON

HIGH RISK OF RENAL IMPAIRMENT DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B

✍ M. Viganò; P. Lampertico; M. Iavarone; G.E. Tontini; F. Facchetti; M. Colombo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Long-term efficacy of entecavir therapy

Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir

✍ M. S. Kwak; J. W. Choi; J. S. Lee; K. A. Kim; J. H. Suh; Y. S. Cho; S. Y. Won; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB